ABSTRACT
Liste desCommissions
The role of endoscopy in the management of inflammatory bowel disease in french gastro enterological private practice: a study based on a sample of 1175 patients.
A I M : The aim of this study was to evaluate the use of endoscopy for the mana9ement of inflammatory bowel disease (IBD) in private practice in France.
M E T H O D S : The entire 9roup of 2,039 French 9astroenterologists in private practice was invited by mail to take part in this study. They had to collect data from all patients with Crohn's disease (CD), ulcerative colitis (UC) or indeterminate colitis tiC) between the 13th and the 25th of October 2003.
RESULTS: 375 practitioners (18,4%)invited to take part in this study participated actively ;1175 files were collected of which 1065 were fully exploitable which corresponded to 533 CD (50%), 498 UC (4.7%) and 34 IC (3%).
Almost all the patients (96%) had had a colonoscopy.
Sigmoidoscopy was performed in 333 patients (31%), more frequently in UC and IC than in CD (respectively 50%, 29% and 13%). Colonoscopies were performed for diagnosis. The median range was 1,79 colonoscopies per patient (1,59 for UC, 1,97 for CD, 1,56 for IC). Half of the sample had only one colonoscopy. An upper endoscopy was performed in 294 CD (55%).
From the 1065 IBD, 881 (82%) had a colonic Iocalisation of their disease. Amon 9 them 427 (48%) had a left colitis, 59 (7%) a pancolitis. Three hundred and seventy seven patients (35%) had su#fered from the disease for more than 8 years.
A colonoscopy was used to research dysplasia for 166 patients (105 UC, 55 CD, 6 IC). Forty five per cent in this 9roup had 1 colonoscopy for screening dysplasia, 20% had 2, 12% 3 and 22% more t ~ n 3 .
Endoscopic dila~tations for benign strictures were performed in 17 patients (4 UC, 12CD, 1 IC):
9 once and only one more than three times.
C O N C L U S I O N : Considerin 9 the methodology of this survey, the significant number of patients examined, from this study, two things can be drawn. We can note: In France, colonoscopy is mainly used for diagnosis (low number of thera- peutic colonoscopies) and that this examination is rarely done more than twice durin 9 the course of the disease. There is a lack of surveillance colonoscopies for screening dysplasia in patients with Ion 9 disease duration.
J. LAPUELLE, ~. TU~AT, P. @UYOT, P. LEVY,
P. HOU(I(.E, ~. PdE, I./AP, P-MOLA~Pr e f : G a s t r o i n t e s t E n d o s c 2 0 0 5 ; 6 t : B 2 5 8
Canc@rologie
E. VAILLANT - 59000 LILLE ericvaillant@alicemail.fr
Endoscopie
J. LAPUELLE - 31400 TOULOUSE jean.lapuelle@wanadoo.fr
Evaluation (EPP)
J.LAURENT - 54000 NANCY jjm.laurent@wanadoo.fr
H@patologie
Po DELASALLE - 06130 GRASSE delassale@club-internet.fr
Informatique
M. M A H E - 22000 SAINT BRIEUX michel.mahe@uni-medecine.fr
MICI
G. TUCAT - 75017 PARIS gtucat@club-internet.fr
Motricitd & Nutrition
A.-L. TARRERIAS - 63400 CHAMALIERES al.terrerias@wanadoo.fr
Pharmacologie
J.-P. JACQUES - 31000 TOULOUSE jacques.gastro@wanadoo.fr
Proctologie
F. DEMULDER - 51100 REIMS devulderf@aol.com
Pratiques Professionnelles
J.-F. ROQUES - 49000 ANGERS jean-francois.roques@wanadoo.fr
Agenda 2005
I er o c t o b r e AG du CREGG
H6tel Ambassador
16, boulevard Haussmann 75009 PARIS
President: P a t r i c k L E V Y 6, rue des cigognes 67000 STRASBOURG T61:03 88 75 53 54
Fax: 03 88 75 15 21 l e v y . p a t @ w a n a d o o . f r Tr~sorier: T h i e r r y H E L B E R T 23, cours Gouff@
13006 MARSEILLE T61:04 91 90 77 70 Fax: 04 91 56 66 90 t . h e l b e r t @ w a n a d o o . f r
Secr~taire G~n~ral: F r a n c k D E V U L D E R 38 bis, rue de Courlancy
51100 REIMS T61:03 26 77 20 60 Fax: 03 26 77 20 71 d e v u l d e r f @ a o l . c o m Conseil d ' a d m i n i s t r a t i o n :
Jean-Marc CANARD, Jean CASSIGNEUL, Jacques CORALLO, Pierre COULOM, Franck DEVULDER, Jean-Luc FRIGUET, Michel GREFF, Philippe GUYOT, Thierry HELBERT, Philippe HOUCKE, Jean-Paul JACQUES, Jean LAPUELLE, Jean-Christophe LETARD, Patrick LEVY, Bernard MARCHETi-I, Bertrand NAPOLEON, Laurent PALAZZO, Ars@ne PAPAZIAN, Michel PELLETIER, Patrice PIENKOWSKI, Jean-Franqois REY, Bruno RICHARD-MOLARD, Gilbert TUCAT, Alain VERDIER.
La lettre du CREGG AstraZeneca~
est r6alis6e et diffus~e avec le soutien
des laboratoires ASTRAZENECA d~p6t 1~9al DENV 5635 - 2005/05 Directeur de la publication: P. LEVY Directeur de la r@daction: Ph. HOUCKE Directeurs associ@s: J. LAURENT Secr~taire de la r~daction: C~line HUGOT Ont particip~ ~ ce num~ro:
JM. CANARD, J. CASSIGNEUL, J. CORALLO, P. COULOM, JS. DELMOTTE, E DEVULDER, JL. FRIGUET, G. GUYOT, PH. HOUCKE, J. LAURENT, P. LEVY, B. MARCHETTI, B. NAPOLEON, A. PAPAZIAN,
P. PIENKOWSKI, B. RICHARD-MOLARD, G. TUCAT, A. VERDIER, E VICARI.
Comit@ de r~daction :
P. LEVY (Strasbour9), TH. HELBERT (Marseilie) E DEVULDER (Reims), J. LAPUELLE (Toulouse) Photos : Ph. HOUCKE, J. LAURENT, B. RICHARD-MOLARD
Edition: ALN Nancy
Conception-Impression:
Ad h,D c
A R R A S -T@I. 03 21 07 07 18
Editions ALN
~
ISBN : 2-914703-14-7 EAN : 9782914703147
